<VariationArchive RecordType="classified" VariationID="29983" VariationName="NG_016313.2:g.(5527_156380)_(156514_166289)del" VariationType="Deletion" Accession="VCV000029983" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-04-18" MostRecentSubmission="2021-04-18">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="38938" VariationID="29983">
      <GeneList>
        <Gene Symbol="AFF2" FullName="ALF transcription elongation factor 2" GeneID="2334" HGNC_ID="HGNC:3776" Source="submitted" RelationshipType="asserted, but not computed">
          <Location>
            <CytogeneticLocation>Xq28</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="148500617" stop="149000663" display_start="148500617" display_stop="149000663" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="147582138" stop="148082192" display_start="147582138" display_stop="148082192" Strand="+" />
          </Location>
          <OMIM>300806</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AFF2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=AFF2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NG_016313.2:g.(5527_156380)_(156514_166289)del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq28</CytogeneticLocation>
      </Location>
      <OtherNameList>
        <Name>121- to 145-KB DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016313.2" sequenceAccession="NG_016313" sequenceVersion="2" change="g.(5527_156380)_(156514_166289)del">
            <Expression>NG_016313.2:g.(5527_156380)_(156514_166289)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.(148501145_148651998)_(148652132_148661907)del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.(148501145_148651998)_(148652132_148661907)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_002025.4" sequenceAccession="NM_002025" sequenceVersion="4" change="c.(47+1_48-1)_(180+1_181-1)del" MANESelect="true">
            <Expression>NM_002025.4:c.(47+1_48-1)_(180+1_181-1)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="300806.0002" DB="OMIM" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NG_016313.2:g.(5527_156380)_(156514_166289)del AND FRAXE" Accession="RCV000022875" Version="4">
        <ClassifiedConditionList TraitSetID="2985">
          <ClassifiedCondition DB="MedGen" ID="C0751157">FRAXE</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2011-08-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2011-08-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-04-18" MostRecentSubmission="2021-04-18">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">21739600</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2985" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6490" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Intellectual developmental disorder, X-linked 109</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Intellectual disability, X-linked, FRAXE type</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">FRAXE intellectual disability</ElementValue>
                <XRef ID="MONDO:0010659" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Fragile XE syndrome</ElementValue>
                <XRef ID="Fragile+XE+Syndrome/2911" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">FRAXE</ElementValue>
                <XRef ID="254288000" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000569189" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000007404" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000507942" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000520051" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000518914" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2378" />
                <XRef ID="2378" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="100973" DB="Orphanet" />
              <XRef ID="C0751157" DB="MedGen" />
              <XRef ID="MONDO:0010659" DB="MONDO" />
              <XRef Type="MIM" ID="309548" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49422" SubmissionDate="2021-04-14" DateLastUpdated="2021-04-18" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300806.0002_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109" title="AFF2, 121- to 145-KB DEL_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109" />
        <ClinVarAccession Accession="SCV000044166" DateUpdated="2021-04-18" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2011-08-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 brothers with mildly to moderately impaired intellectual development, speech delay, and behavioral abnormalities including autistic features (MRX109; 309548), Stettner et al. (2011) identified a 121 to 145-kb deletion within the FMR2 gene, resulting in the complete loss of exon 3. The asymptomatic mother and an affected uncle of the boys also carried the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">21739600</ID>
              </Citation>
              <XRef DB="OMIM" ID="309548" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="AFF2" />
          </GeneList>
          <Name>AFF2, 121- to 145-KB DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">121- to 145-KB DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300806.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49422" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 109" MappingRef="Preferred">
        <MedGen CUI="C0751157" Name="FRAXE" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

